Diligence memo · auto-generated · as of July 2, 2026
Epikast Inc.
Epikast Inc. looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
Epikast Inc. operates in Other Health Care, based in Brooklyn.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Epikast Inc. has raised $5.7M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $5.0M on 2023-02-16.
Most recent recorded round closed around 2026-01-22.
Valuation (modeled)modeled
Provath models Epikast Inc. at approximately $1.9M (range $897K–$2.9M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.12× the median modeled value of Series A Other Health Care companies in 2025–2027 (83 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 35 months.
Last raise 5 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round was 7.1× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 67% of Other Health Care peers (5377 compared).
Modeled value ranks above 9% of those peers.
Closest niche peers: HelloJoy, Inc., Maui Imaging, Inc., Celltrio, Inc., Medmo, Inc., Vertical Orthopaedics, Inc..
Peoplefiled
7 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.